The Future Doesn’t Fit in Boxes. Neither Do We.
We back seed-stage founders where computation meets biology—fueling the breakthroughs that will transform how we live, age, and protect our planet.
Where Code Meets Creation
At H Tree, we focus on the intersection of computation and biology—backing founders who redefine what’s possible. From AI-driven drug discovery to enzyme-based carbon capture, we invest where the future takes shape. In the space between disciplines, where the most groundbreaking high impact opportunities always lie, that’s where you’ll find us. And that’s where we’ll build the future with you. Learn more
“Vanela and Rob have the conviction to support first-time founders with ideas. There is no question, we wouldn't be where we are without them.”
Arne Scheu
Co-founder, Valink Therapeutics
“The "tech in bio" VC landscape is sparse at the seed rounds and very few funds, like H Tree, have the competence to balance the software plus the bio expertise.”
Jack O’Meara
Co-founder, Ochre Bio
Our focus
-
We invest globally in seed-stage companies as lead or co-lead. We often commit to follow-on investments in our portfolio companies.
-
Our usual ticket size is between 2-3m EUR.
-
We focus on the intersection of computation and biology within human and planetary health.
-
We like to aim for an ownership position between 10% to 20%.